The Hindu·2 min read·easy
Omnigel strengthens its portfolio with the introduction of Omnigel Maxstrong
C
cuelive
✦AI Summary
Cipla Health has launched Omnigel Maxstrong, a new 2% diclofenac pain relief product available in gel and spray formats. This expansion marks the brand's entry into a more advanced pain management category with updated premium packaging.
Why it matters
Product portfolio expansion in the wellness sector reflects growing consumer demand for specialized, long-lasting pain relief solutions.
The new variant is built for individuals whose active routines often lead to repeated muscle and joint discomfort
healthbusiness
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The text is a factual report on a product launch and brand strategy.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in